Go to Pathways list
Support our work
DONATE NOW

The impact of COVID19 on drug development and the future of clinical trials

E-session 530002 / NO CME
Add to My Agenda

Expert:

Anastasios Stathis, expert of session 'The impact of COVID19 on drug development and the future of clinical trials'

Anastasios Stathis
Oncology Institute of Southern Switzerland
Bellinzona, Switzerland

Expert:

Normand Blais, expert of session 'The impact of COVID19 on drug development and the future of clinical trials'

Normand Blais
CHUM- Notre Dame Hospital
Montreal, Canada

Expert:

Daniel Heng, expert of session 'The impact of COVID19 on drug development and the future of clinical trials'

Daniel Heng, Clinical Professor and Head, Medical Oncology
Tom Baker Cancer Center
Calgary, Canada

Discussant:

Ramon Andrade Bezerra de Mello, expert of session 'The impact of COVID19 on drug development and the future of clinical trials'

Ramon Andrade Bezerra de Mello
Federal University of São Paulo (UNIFESP)
São Paulo, Brazil

Share on:

This session is part of the following pathway(s):

COVID-19 - Impact in oncology

08
Jun 2020
18:15-19:00 CET

Top